2020
DOI: 10.1016/j.wneu.2020.07.102
|View full text |Cite
|
Sign up to set email alerts
|

Dorsal Root Ganglion Stimulation for the Treatment of Chronic Neuropathic Knee Pain

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
16
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 15 publications
(19 citation statements)
references
References 16 publications
3
16
0
Order By: Relevance
“…Total of 5 patients had complications (16.7%) Morgalla et al (2019) [ 52 ] Germany Prospective with single arm Multiple institutional funding sources 12 Unilateral localized neuropathic pain in the lower limbs or inguinal region 51.8 ± 6.05 DRG-S At 1 and 6 months follow-ups, N2–P2 amplitudes were significantly greater and NRS scores significantly lower compared to baseline. There was a negative correlation between LEP amplitudes and NRS scores Martin et al (2020) [ 53 ] UK Retrospective Grant funding from National Institute for Health Research Oxford Biomedical Research Centre Total: 14 Single L3 lead: 8 Single L4 lead: 1 L3 and L4 leads: 3 Chronic neuropathic knee pain 49.2 DRG-S Median preoperative NRS was 8.5 and median postoperative NRS was 2. The median improvement in pain score was 80%.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Total of 5 patients had complications (16.7%) Morgalla et al (2019) [ 52 ] Germany Prospective with single arm Multiple institutional funding sources 12 Unilateral localized neuropathic pain in the lower limbs or inguinal region 51.8 ± 6.05 DRG-S At 1 and 6 months follow-ups, N2–P2 amplitudes were significantly greater and NRS scores significantly lower compared to baseline. There was a negative correlation between LEP amplitudes and NRS scores Martin et al (2020) [ 53 ] UK Retrospective Grant funding from National Institute for Health Research Oxford Biomedical Research Centre Total: 14 Single L3 lead: 8 Single L4 lead: 1 L3 and L4 leads: 3 Chronic neuropathic knee pain 49.2 DRG-S Median preoperative NRS was 8.5 and median postoperative NRS was 2. The median improvement in pain score was 80%.…”
Section: Resultsmentioning
confidence: 99%
“…Similarly, Martin et al [ 69 ] conducted a secondary analysis of a prospective study of 14 patients with neuropathic knee pain. Of 14 patients, 12 had a successful trial and received a permanent implant, including five patients with postsurgical knee pain and seven patients with pain secondary to traumatic injury.…”
Section: Resultsmentioning
confidence: 99%
“…Twelve of the 14 had greater than 50% reduction of their pain. 227 Similarly, in the FOCUS study, 12 patients with total knee replacements had successful treatment of their pain after DRG stimulation. 228 The efficacy of DRG treatment for post-operative pain associated with TKA has additionally been supported by Morgella et al’s outcomes, with 27 patients implanted with DRG systems demonstrating a reduction in VAS of approximately 69%.…”
Section: Recommendations Regarding Neurostimulationmentioning
confidence: 96%
“…1 Since then, smaller studies have demonstrated the efficacy of DRG-S in treating other neuropathic pain conditions and mixed nociceptive pain syndromes, including axial low back pain and postsurgical joint pain. [2][3][4][5] Although DRG-S can produce paresthesia in the covered anatomy at high stimulation amplitudes, paresthesia is usually neither required nor preferred. Unlike paresthesia-dependent conventional SCS, DRG-S is typically applied at subthreshold amplitudes, which are imperceptible.…”
Section: Introductionmentioning
confidence: 99%